Grant J, Saldanha JW, Gould AP. (2010) A Drosophila model for primary coenzyme Q deficiency and dietary rescue in the developing nervous system. Dis Model Mech. 3(11-12):799-806.
Lintern KB, Guidato S, Rowe A, Saldanha JW, Itasaki N. (2009) Characterization of wise protein and its molecular mechanism to interact with both Wnt and BMP signals. J Biol Chem. 284(34):23159-68.
Qi W, Cooke LS, Stejskal A, Riley C, Croce KD, Saldanha JW, Bearss D, Mahadevan D. (2009) MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer. BMC Cancer. 9:142.
Riley CJ, Engelhardt KP, Saldanha JW, Qi W, Cooke LS, Zhu Y, Narayan ST, Shakalya K, Croce KD, Georgiev IG, Nagle RB, Garewal H, Von Hoff DD, Mahadevan D. (2009) Design and activity of a murine and humanized anti-CEACAM6 single-chain variable fragment in the treatment of pancreatic cancer. Cancer Res. 69(5):1933-40.
Green RC, Thumser AE, Povey D, Saldanha JW, Potter BS, Palmer RA, Howlin BJ. (2009) A comparative study of the single crystal X-ray determination and molecular modelling of the binding of oligomycin to ATP synthase. Comput Biol Chem. 33(3):189-95.
Hunt DM, Saldanha JW, Brennan JF, Benjamin P, Strom M, Cole JA, Spreadbury CL, Buxton RS. (2008) Single nucleotide polymorphisms that cause structural changes in the cyclic AMP receptor protein transcriptional regulator of the tuberculosis vaccine strain Mycobacterium bovis BCG alter global gene expression without attenuating growth. Infect Immun. 76(5):2227-34.
The author is an inventor on the following patents concerning humanized antibodies (Publication Numbers obtained from a public database) and others which are not yet published.